ATH
Click for more information
0.00% 0.4¢ alterity therapeutics limited

Ann: New Publication Demonstrates ATH434 is Neuroprotective, page-6

  1. gumboot
    383 Posts.
    lightbulb Created with Sketch. 19
    clock Created with Sketch.
    15/07/21
    13:40
    Post #: 54525205
    I have added for the first time since buying back in a year ago. Whilst I believe the more immediate and greater value is in PBT2, on reading the paper it should be viewed by neurologists as important.
    Maybe the last placement saw a release prior to peer review
    ATH Price at posting: 3.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢ 		Change
0.000(0.00%) 		Mkt cap ! $20.98M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
58 67819949 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 37853590 23
View Market Depth
Last trade - 10.42am 03/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.